Title:
【発明の名称】認識増強剤としてのα,αージ置換芳香族化合物およびヘテロ芳香族化合物
Document Type and Number:
Japanese Patent JP2563522
Kind Code:
B2
Abstract:
Cognitive defeciencies or neurological dysfunction in mammals are treated with alpha , alpha -disubstituted aromatic or heteroaromatic compounds. The compounds have the formula: or a salt thereof wherein X and Y are taken together to form a saturated or unsaturated carbocyclic or heterocyclic first ring and the shown carbon in said ring is alpha to at least one additional aromatic ring or heteroaromatic ring fused to the first ring; one of Het<1> or Het<2> is 2, 3, or 4-pyridyl or 2, 4, or 5-pyrimidinyl and the other is selected from (a) 2, 3, or 4-pyridyl, (b) 2, 4, or 5-pyrimidinyl, (c) 2-pyrazinyl, (d) 3, or 4-pyridazinyl, (e) 3, or 4-pyrazolyl, (f) 2, or 3-tetrahydrofuranyl, and (g) 3-thienyl. i
Inventors:
RICHAADO ARAN AARU
MERUBIN JON MAIAAZU
BIKUTAA YOOHANESU NIKORUSON
MERUBIN JON MAIAAZU
BIKUTAA YOOHANESU NIKORUSON
Application Number:
JP25004288A
Publication Date:
December 11, 1996
Filing Date:
October 05, 1988
Export Citation:
Assignee:
DEYUHON MERUKU PHARM CO ZA
International Classes:
C07D213/127; A61K31/44; A61K31/4409; A61K31/4418; A61K31/4427; A61K31/443; A61K31/4433; A61K31/495; A61K31/50; A61K31/505; A61K31/54; A61P25/28; C07D213/16; C07D213/24; C07D213/26; C07D213/30; C07D213/32; C07D213/34; C07D213/38; C07D213/40; C07D213/50; C07D213/53; C07D213/57; C07D239/26; C07D241/36; C07D311/08; C07D335/10; C07D401/06; C07D401/10; C07D401/14; C07D403/10; C07D403/14; C07D405/06; C07D405/10; C07D405/14; C07D409/06; C07D409/10; C07D409/14; C07D471/04; (IPC1-7): C07D213/26; A61K31/44; A61K31/495; A61K31/505; A61K31/54; C07D213/30; C07D213/34; C07D213/38; C07D213/50; C07D401/10; C07D401/14; C07D403/10; C07D403/14; C07D405/10; C07D405/14; C07D409/10; C07D409/14
Domestic Patent References:
| JP62277381A |
Attorney, Agent or Firm:
Chika Takagi (2 outside)